University of Granada at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

University of Granada brings 2 presentations to ESGCT 2026 in Hamburg. Its work spans gene therapy platforms for Pompe disease and safer CAR T cell design. One project builds an activation-inducible promoter so a CAR T therapy switches on only when the cells are activated.

OrganizationESGCT 2026 Attendance
University of Granada
Granada, Spain
Poster
Wed Oct 28
1:30pm–3:30pm
Optimization of gene therapy platforms for the treatment of Pompe Disease
Lentiviral vectors / Integrative vectors
Poster
Thu Oct 29
2:00pm–4:00pm
ALHAMBRA: An activation-inducible promoter for safer and more controllable next-generation CAR-T therapies
Immunotherapy and CAR T cells

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Granada

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction